You must be logged in and verified to contact the designer.
Product Description
3D print of Victoza. Model created from PDB ID: 4APD. Model Description
This is a 3D print of GLP-1 Analog (Victoza) in Complex with GLP-1 Receptor and visualized as a volumetric surface. Protein Description Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenousmetabolichormoneGLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment forobesity in adults with at least one weight-related comorbid condition.
We're sorry to inform you that we no longer support this browser and can't confirm that everything will work as expected. For the best Shapeways experience, please use one of the following browsers: